Nonalcoholic Steatohepatitis (NASH) Models

Nonalcoholic steatohepatitis (NASH) is characterized by the presence of fibrosis and inflammation in a liver with an elevated lipid deposition. There is a large—and unmet—need in the clinical community for therapies and a wide range of animal models that can be used to test novel therapeutics for this disease.

Our Discovery scientists would be happy to discuss animal models of NASH that are currently under validation, supported by the world’s largest group of certified veterinary pathologists, who have years of experience with liver-specific histology endpoints.

You may also be interested in...

Discovery Pathology

We offer extensive resources dedicated to pathology support for your drug discovery activities.